G. Pommier

582 total citations
24 papers, 465 citations indexed

About

G. Pommier is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Pommier has authored 24 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Pommier's work include Cancer, Hypoxia, and Metabolism (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Glycosylation and Glycoproteins Research (3 papers). G. Pommier is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Glycosylation and Glycoproteins Research (3 papers). G. Pommier collaborates with scholars based in France and Morocco. G. Pommier's co-authors include Jacques Marvaldi, M Remacle-Bonnet, Françoise Garrouste, Frederic André, Scott Heller, Jacques Fantini, J. B. Rognoni, Jean‐Michel Culouscou, R Depieds and José Luis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

G. Pommier

24 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Pommier France 11 242 169 97 92 61 24 465
G. G. Chen China 11 269 1.1× 156 0.9× 115 1.2× 116 1.3× 38 0.6× 15 567
Timothy R. McPhee Canada 5 369 1.5× 93 0.6× 60 0.6× 148 1.6× 40 0.7× 6 590
Susumu Kajihara Japan 12 173 0.7× 62 0.4× 70 0.7× 86 0.9× 29 0.5× 17 486
Zhimin Liu China 15 357 1.5× 163 1.0× 213 2.2× 241 2.6× 100 1.6× 32 741
Bosco Shang Wang United States 12 162 0.7× 37 0.2× 105 1.1× 110 1.2× 125 2.0× 38 422
Stéphanie Rodriguez United States 14 198 0.8× 104 0.6× 118 1.2× 66 0.7× 50 0.8× 24 747
Jun Seop Yun South Korea 13 310 1.3× 80 0.5× 67 0.7× 50 0.5× 33 0.5× 20 513
Renpin Chen China 14 177 0.7× 71 0.4× 83 0.9× 120 1.3× 87 1.4× 27 505
Catherine A. Shang Australia 12 232 1.0× 112 0.7× 75 0.8× 80 0.9× 96 1.6× 21 505
Xiwu Chen United States 10 194 0.8× 36 0.2× 93 1.0× 63 0.7× 49 0.8× 10 444

Countries citing papers authored by G. Pommier

Since Specialization
Citations

This map shows the geographic impact of G. Pommier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Pommier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Pommier more than expected).

Fields of papers citing papers by G. Pommier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Pommier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Pommier. The network helps show where G. Pommier may publish in the future.

Co-authorship network of co-authors of G. Pommier

This figure shows the co-authorship network connecting the top 25 collaborators of G. Pommier. A scholar is included among the top collaborators of G. Pommier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Pommier. G. Pommier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bardin, Nathalie, G. Pommier, & Marielle Sanmarco. (2006). Can cryoglobulins interfere with the measurement of IgM antiphosphatidylethanolamine antibodies by ELISA?. Thrombosis Research. 119(4). 441–446. 3 indexed citations
2.
Garrouste, Françoise, M Remacle-Bonnet, Cyril Fauriat, et al.. (2002). Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells–evidence for a NF-κB-dependent survival mechanism. Cell Death and Differentiation. 9(7). 768–779. 30 indexed citations
3.
Dadoun, F., G. Pommier, N. Sauze, et al.. (2000). IGF-I/IGFBPs system response to endotoxin challenge in sheep. Journal of Endocrinology. 164(3). 361–369. 33 indexed citations
4.
Remacle-Bonnet, M, Françoise Garrouste, Scott Heller, et al.. (2000). Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.. PubMed. 60(7). 2007–17. 127 indexed citations
5.
Braguer, Diane, et al.. (1999). Tau protein is involved in the apoptotic process induced by anti-microtubule agents on neuroblastoma cells. APOPTOSIS. 4(1). 47–58. 19 indexed citations
7.
Remacle-Bonnet, M, et al.. (1996). Serum Factors Inhibit Melanoma Cell Surface Expression of Type I and Type II IGF Receptors. Journal of Receptors and Signal Transduction. 16(1-2). 115–134. 2 indexed citations
9.
Lehmann, Maxime, M Remacle-Bonnet, Françoise Garrouste, et al.. (1994). Surface Distribution of the EGF Receptor During Differentiation of the Human Colon Carcinoma Cell Line HT29-D4. Journal of Receptor Research. 14(5). 319–333. 5 indexed citations
10.
Pommier, G., et al.. (1993). Potential role of IGFBPS in the regulation of the differentiation state of human colonic carcinoma cells.. PubMed. 3(1). 80–2. 10 indexed citations
11.
Pommier, G.. (1992). [Growth factors and intestinal cancers].. PubMed. 79(5). 427–49. 2 indexed citations
12.
Culouscou, Jean‐Michel, et al.. (1992). Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line.. The Journal of Clinical Endocrinology & Metabolism. 75(2). 609–616. 28 indexed citations
13.
Fantini, Jacques, et al.. (1989). Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. Journal of Biological Chemistry. 264(17). 10282–10286. 77 indexed citations
14.
Pommier, G., Jean‐Michel Culouscou, Françoise Garrouste, & M Remacle-Bonnet. (1988). CRGF: An Autocrine Growth Factor Associated with Colorectal Carcinomas. Annals of the New York Academy of Sciences. 551(1). 382–384. 5 indexed citations
15.
Grob, Jean‐Jacques, et al.. (1987). Contact urticaria from rifamycin. Contact Dermatitis. 16(5). 284–285. 8 indexed citations
16.
Pommier, G., Françoise Garrouste, M Remacle-Bonnet, & R Depieds. (1986). Immunomodulating activities associated with the cytosol fraction of a 3-methylcholanthrene-induced rat fibrosarcoma—II. Association with polyamine complexes. International Journal of Biochemistry. 18(6). 557–564. 1 indexed citations
17.
Culouscou, Jean‐Michel, et al.. (1986). Enhancement of Production of Superoxide Anion by Human Polymorphonuclear Leukocytes Exposed to Products of the HT-29 Human Colonic Adenocarcinoma Cell Line. JNCI Journal of the National Cancer Institute. 77(6). 1225–34. 3 indexed citations
18.
Culouscou, Jean‐Michel, et al.. (1986). Immunosuppressive properties of human placenta: study of supernatants from short-term syncytiotrophoblast cultures. Journal of Reproductive Immunology. 9(1). 33–47. 24 indexed citations
19.
Marco, María Paz, et al.. (1984). Immunomodulating Activities Associated With the Cytosol Fraction of a 3-Methylcholanthrene-Induced Rat Fibrosarcoma<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 72(5). 1101–11. 4 indexed citations
20.
Pommier, G., Patrick J. Cozzone, & G. Marchis-Mouren. (1974). The sulfhydryl groups of porcine pancreatic α-amylase: unmasking, reactivity and function. Biochimica et Biophysica Acta (BBA) - Enzymology. 350(1). 71–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026